Both in Pharmaceuticals
Heron Therapeutics vs Citius Oncology
Over the past year HRTX returned −73.8% and CTOR returned −65.2%; their daily moves had a correlation of 0.09.
HRTX −73.8% CTOR −65.2%Growth of $1, one year, split-adjusted
| Metric | HRTX | CTOR |
|---|---|---|
| Price | $0.2986 | $0.5470 |
| Market cap | $56.7M | $57.9M |
| Today | +4.88% | −0.55% |
| 1 month | −10.0% | −35.6% |
| 6 months | −77.2% | −39.8% |
| Year to date | −77.0% | −45.3% |
| 1 year | −74.7% | −67.2% |
| Revenue growth (YoY) | +1.3% | — |
| Gross margin | 69.3% | 67.1% |
| Net margin | −14.6% | −597.4% |
| P/E (TTM) | — | — |
| Price / sales | 0.4× | 8.1× |
| Net cash | -$100.0M | $10.2M |
| Dividend yield | — | — |
| Volatility (60d) | 88.0% | 98.9% |
| Short % of float | 25.7% | 0.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).